相关实验视频

Updated: Jun 21, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

类固醇药物治疗提高了无法切除的第三阶段肺状细胞癌的存活率,同时进行化疗或放射治疗

Chih-Hsien Yu¹, Kuan-Chou Lin^2,3, Chia-Lun Chang^4,5

¹Department of Cardiology, St. Paul's Hospital Taoyuan, Taiwan.

American journal of cancer research

|July 15, 2024

概括

在化疗放射治疗期间使用他类药物显著改善了不可切除的第三阶段肺状细胞癌的存活率. 普拉瓦斯塔丁和罗斯瓦斯塔丁等特定的他类药物显示出最多的益处,观察到剂量反应效应.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

无法切除的第三阶段肺状细胞癌 (LSCC) 是一个重大的治疗挑战.
同时化疗放射治疗 (CCRT) 是一种标准治疗,但可以改善生存结果.

研究的目的:

为了研究在CCRT期间使用他类药物的影响整体存活率 (OS) 和肺癌特异性存活率 (LCSS) 在无法切除的III期LSCC患者中.

主要方法:

一项倾向性得分匹配队列研究利用了来自台湾癌症注册表和国家健康保险研究数据库的数据.
分析的重点是比较在CCRT期间使用他类药物的患者和不使用他类药物的患者之间的OS和LCSS.

主要成果:

在CCRT期间使用静止剂独立地与OS (aHR 0.60,P < 0.0001) 和LCSS (aHR 0.61,P < 0.0001) 的显著改善有关.
普拉瓦斯塔丁和弗卢瓦斯塔丁显示出降低LCSS的最大潜力,其次是罗斯瓦斯塔丁,阿托瓦斯塔丁,西姆瓦斯塔丁和洛瓦斯塔丁.
观察到剂量与反应的关系,较高的他类药物的累积定义每日剂量和每日强度与降低的死亡率有关.

结论:

在CCRT治疗不可切割的III期LSCC期间使用他类药物与生存率的大幅改善有关.
特定的他类药物,特别是普拉瓦斯塔丁和罗斯瓦斯塔丁,在提高肺癌特异性生存率方面似乎最有效.
这些发现支持进一步调查他类药物作为LSCC治疗中的辅助疗法.

关键词:

肺状细胞癌是肺的状细胞癌.同时进行化学或放射治疗.死亡率死亡率斯塔丁斯塔丁斯是一个国家.不能切割的不可切割的

更多相关视频

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...